Treatment to Clear Resistant Bacteria from Your Gut
Part of Infections clinical trials.
This study tests whether a new treatment called BM111 can safely clear two types of antibiotic-resistant bacteria (CRE and VRE) that live in your intestines without causing infection. You'd provide stool samples over several weeks to see if the bacteria levels drop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old
- You carry CRE or VRE bacteria in your stool (confirmed by testing) but have no active infection from these bacteria
- You have not had major bowel surgery (like colon removal) or a fecal microbiota transplant in the past
- You are not severely ill, not in the ICU, and not on a breathing machine or intensive medications for sepsis or shock
- You are willing to provide stool samples and avoid certain medications (antibiotics, acid-reducers, probiotics) for at least one week before and during the study
- You do not have active cancer being treated, a recent organ transplant, severe immune system problems, or severe blood/liver/kidney abnormalities
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This Phase 2 study tests whether an investigational treatment can help clear or reduce antibiotic-resistant bacteria living in the gut. It may help prevent these germs from causing future infections by targeting specific resistant bacteria found on stool or rectal swabs.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
This trial tests three different ways to clear antibiotic-resistant bacteria from your gut using fecal microbiota transplant (FMT). It may help if you have a confirmed resistant infection and are looking for a treatment to reduce the risk of future infections.
Hear when a new VRE Colonization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.